A major limitation of our in vitro study is that all experimental data are generated in a single neuroblastoma cell line, SH-SY5Y, which is an MYCN-non-amplified NB cell model that represents only low- and intermediate-risk NB. The gene discussed is MYCN; the disease is neuroblastoma.